返回
Legionnaires disease
DOI:10.1016/j.lpm.2006.10.012.png)
摘要
En 中文
Legionnaires disease, more formally known as legionellosis, is a relatively common form of severe pneumonia caused by Legionella, a genus of waterborne bacteria. Legionellosis is acquired by inhalation of legionellae from contaminated environmental sources. Legionella pneumophila serogroup 1 is responsible for more than 80% of cases in most countries. More than 1500 cases were reported in France in 2005. Initial diagnosis is based on tests for urinary antigens. The mortality rate for legionellosis depends on the promptness of appropriate antibiotic therapy. Macrolides (erythromycin or intravenous azithromycin, which is preferred to erythromycin for its better pharmucodynamic properties) and fluoroquinolones (levofloxocin) ore the antibiatics of choice for severe legionellosis.
Keyword:
COMMUNITY-ACQUIRED PNEUMONIA
LEGIONELLA-PNEUMOPHILA
EFFICACY
THERAPY
SUSCEPTIBILITY
TELITHROMYCIN
LEVOFLOXACIN
MACROPHAGES
RECEPTOR-4
SEQUENCE
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
P
IF:
3.4
论文数:
4.5K
被引数:
2.3K
机构
暂无机构信息
引用论文
Radiocarbon Dates of Late Quaternary Megafauna and Botanical Remains from Central Alberta, Canada
Radiocarbon
IF0
Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity
NATURE GENETICS
IF31.8

